The JDRF Mary Tyler Moore and S. Robert Levine, M.D.,Excellence in Clinical Research Award recognizes outstanding clinical and translational type 1 diabetes research, and is named in honor of JDRF's International Chairman, Mary Tyler Moore - who had type 1 diabetes - and her husband, S. Robert Levine, MD, for their extraordinary commitment to JDRF's mission. This prestigious award has been given every year since 2004, and with Moore’s passing in January, it is especially significant this year. Please help us recognize her tremendous legacy by nominating someone today!
About Mary Tyler Moore and S. Robert Levine, M.D.
Mary Tyler Moore tirelessly committed herself to helping the millions with T1D. She served as JDRF’s International Chairman for over 30 years, and her highly visible public service campaigns helped to strengthen JDRF’s research and advocacy efforts. She and her husband, Dr. S. Robert Levinehave contributed generously to JDRF, initiating such programs as JDRF’s Stem Cell Research Fund. A leading JDRF volunteer, Dr. Levine has served on the International Board of Directors, Research Committee, Executive Committee, and as Chairman of the Board committees for Clinical Affairs, Government Relations Marketing and Communications, and IT. Dr. Levine is currently a JDRF Chancellor.
About the Mary Tyler Moore and S. Robert Levine, M.D., Excellence in Clinical Research Award
JDRF is now accepting nominations for the Mary Tyler Moore and S. Robert Levine, M.D., Excellence in Clinical Research Award. We aim to recognize individuals who have made major contributions to any area of clinical and translational Type 1 Diabetes research.
Please help JDRF identify the best candidates for this honor! Submit your nominations by Friday, March 3, 2017 directly to Kelbi Culwell, Research Coordinator, at . Please include the following information in your response:
Your First Name
Your Last Name
Nominee’s First Name
Nominee’s Last Name
Nominee’s Institution
Nominee’s Area of Expertise
Pioneering, seminal, meritorious contribution to Type 1 Diabetes, including role of nominee (200 characters):
How has this contribution changed research directions of Type 1 Diabetes, been translated, and/or had clinical impact on Type 1 Diabetes? (200 characters):
If you already nominated someone for a Grodsky or Rumbough Award, you may also nominate them for the Mary Tyler Moore and S. Robert Levine, M.D., Excellence in Clinical Research Award. Please contact Kelbi Culwell () with any questions.